US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Dova Pharmaceuticals Inc (DOVA)
Dova Pharmaceuticals Inc (DOVA) ニュース

DOVA

Dova Pharmaceuticals (DOVA)

Dova Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:DOVA

1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2019/11/23	06 : 13	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/19	20 : 01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/18	20 : 02	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06 : 44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06 : 43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06 : 42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06 : 41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06 : 40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06 : 39	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06 : 38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06 : 37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06 : 36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06 : 36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06 : 35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/12	23 : 44	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/12	23 : 35	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/12	23 : 33	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/12	23 : 32	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/12	23 : 30	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/12	23 : 26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/12	23 : 19	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/12	20 : 07	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/02	06 : 03	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/02	06 : 01	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/10/18	00 : 23	PR Newswire (US)	Moore Kuehn, PLLC Encourages Milacron Holdings Corp. (MCRN), Ecology & Environmental, Inc. (EEI), Pivotal Software, Inc. (PVT...	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/10/12	06 : 16	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/10/12	06 : 09	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/10/05	07 : 12	PR Newswire (US)	SHAREHOLDER ALERT: WeissLaw LLP Investigates Dova Pharmaceuticals, Inc.	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/10/04	05 : 10	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/10/04	05 : 09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DOVA	Dova Pharmaceuticals Inc

Showing the most relevant articles for your search:NASDAQ:DOVA

1 2 3 4 5 6 7 8 次へ >>

US Dollar vs Yen

Financial Select Sector

Gold vs US Dollar

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約